Death-Associated Protein Kinase Loss of Expression Is a New Marker for Breast Cancer Prognosis
暂无分享,去创建一个
A. Kimchi | W. Rostène | A. Gompel | D. Hugol | G. Plu-bureau | Y. Decroix | D. Lévy | G. Plu-Bureau
[1] William Rostène,et al. Antiestrogens are pro‐apoptotic in normal human breast epithelial cells , 2003, International journal of cancer.
[2] Michael J Thun,et al. Long‐term trends in cancer mortality in the United States, 1930–1998 , 2003, Cancer.
[3] U. Lehmann,et al. Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype. , 2002, Cancer research.
[4] Ruey-Hwa Chen,et al. DAP-kinase induces apoptosis by suppressing integrin activity and disrupting matrix survival signals , 2002, The Journal of cell biology.
[5] W. Farrell,et al. Preferential loss of Death Associated Protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion , 2002, Oncogene.
[6] H. Ng,et al. Frequent death-associated protein kinase promoter hypermethylation in multiple myeloma. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[7] A. Kimchi,et al. DAP-kinase: from functional gene cloning to establishment of its role in apoptosis and cancer , 2001, Cell Death and Differentiation.
[8] William Rostène,et al. Hormonal regulation of apoptosis in breast cells and tissues , 2000, Steroids.
[9] F. Khuri,et al. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. , 2000, Journal of the National Cancer Institute.
[10] Gustavo Droguett,et al. DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation , 2000, Nature Cell Biology.
[11] J. Herman,et al. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. , 1999, Blood.
[12] M. Inganäs,et al. Prognostic value of P53 gene mutations in a large series of node-negative breast cancer patients. , 1998, Cancer research.
[13] S. Polak‐Charcon,et al. DAP kinase links the control of apoptosis to metastasis , 1997, Nature.
[14] Peter A. Jones,et al. DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene , 1997, Oncogene.
[15] A. Kimchi,et al. DAP‐kinase is a Ca2+/calmodulin‐dependent, cytoskeletal‐associated protein kinase, with cell death‐inducing functions that depend on its catalytic activity , 1997, The EMBO journal.
[16] A. Gompel,et al. Antagonism between estradiol and progestin on Bcl‐2 expression in breast‐cancer cells , 1996, International journal of cancer.
[17] Z. Darżynkiewicz. Apoptosis in anititumor strategies: Modulation of cell cycle or differentiation , 1995, Journal of cellular biochemistry.
[18] A. Kimchi,et al. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. , 1995, Genes & development.
[19] K. Keyomarsi,et al. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. , 1991, Cancer research.
[20] I. Mowszowicz,et al. Estradiol and progesterone receptors in cultured normal human breast epithelial cells and fibroblasts: immunocytochemical studies. , 1991, The Journal of clinical endocrinology and metabolism.
[21] P. Spritzer,et al. Progestin effect on cell proliferation and 17 beta-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. , 1986, The Journal of clinical endocrinology and metabolism.
[22] Ruth P. Mack,et al. Long-Term Trends , 2011 .